Vertex Rare Disease Drug Kalydeco Receives EU Approval To Treat Cystic Fibrosis Patients

Vertex_Pharma_Logo

Great news for the cystic fibrosis community.  Vertex Pharmaceuticals announced that European regulators have approved its new rare disease drug Kalydeco to treat cystic fibrosis (CF), a rare and often fatal inherited disease, which causes mucus to thicken and block the passage of air to [...]